Key result
Higher body cell mass is linked to ~12% higher odds of metabolic syndrome per SD.
Why the study?
An accompanying letter raised methodological considerations regarding a prior study of BMI-adjusted body cell mass (BCMbmi) and lean body mass (LBMbmi), specifically the potential influence of the BMI denominator on associations with metabolic syndrome and insulin resistance and the interpretation of differences between BCMbmi and LBMbmi.
Is greater absolute body cell mass independently associated with lower odds of metabolic syndrome and insulin resistance after accounting for BMI in middle-aged and older Korean adults?
Is greater absolute body cell mass independently associated with lower odds of metabolic syndrome and insulin resistance after accounting for BMI in middle-aged and older Korean adults?
Answers are grounded in this paper and cite their sources.
After accounting for BMI separately, absolute body cell mass is not inversely associated with metabolic syndrome or insulin resistance, indicating that BMI-adjusted body cell mass reflects a relative body-composition index influenced by its denominator.
We recently reported associations of body mass index (BMI)-adjusted body cell mass (BCMbmi) and BMI-adjusted lean body mass (LBMbmi) with metabolic markers, metabolic syndrome (MetS), and insulin resistance (IR) in middle-aged and older Korean adults. 1 In the accompanying Letter, the author raised two important methodological considerations: the potential influence of the denominator on associations involving BCMbmi and the interpretation of differences between BCMbmi and LBMbmi.We thank the author for the opportunity to examine and clarify these issues.First, we agree that associations involving a ratio-based measure may be influenced by its denominator.2 To assess this possibility, we conducted additional sex-stratified sensitivity analyses that included absolute BCM and BMI simultaneously as separate continuous variables.BCM and BMI were standardized within each sex.The models were adjusted for age, smoking status, alcohol consumption, regular exercise, household income, and marital status.Body weight was excluded because BMI was already included in the models.After accounting for BMI, absolute BCM was not inversely associated with MetS or IR (Table 1).Among men, each one-standarddeviation increase in absolute BCM was associated with an odds ratio (OR) of 1.12 for MetS (95% confidence interval [CI], 1.02 to 1.23; P= 0.017) and 0.94 for IR (95% CI, 0.85 to 1.02; P= 0.148).Among women, the corresponding ORs were 1.21 for MetS (95% CI, 1.12 to 1.31; P< 0.001) and 1.12 for IR (95% CI, 1.03 to 1.21; P= 0.005).These findings show that the inverse associations observed for BCMbmi did not persist when absolute BCM and BMI were modeled separately.Therefore, our original findings should not be interpreted as evidence that greater absolute BCM was independently associated with lower odds of MetS or IR.BCMbmi is better interpreted as a relative body-composition index reflecting BCM in relation to BMI.Properties related to the denominator may have influenced the direction and magnitude of the observed associations.Second, we agree that small differences in the area under the receiver operating characteristic curve do not necessarily indicate bi-
No takes yet. Share an insight, caveat, or question.
Cho et al. (2026) conducted a letter in Metabolic syndrome and insulin resistance. Absolute body cell mass (BCM) per 1-SD increase was evaluated on Metabolic syndrome (MetS) (OR 1.12, 95% CI 1.02-1.23, p=0.017). Absolute body cell mass adjusted for BMI was positively associated with metabolic syndrome in men (OR 1.12; 95% CI 1.02-1.23) and women (OR 1.21; 95% CI 1.12-1.31).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: